Nvidia Partners With Alphabet Spinoff on Drug Discovery Tech
- Advancement of Nvidia chips makes faster simulation possible
- SandboxAQ, valued at $4 billion, builds quantum-based software
This article is for subscribers only.
Nvidia Corp. and SandboxAQ, a startup spun off from Alphabet Inc., are working together to help companies simulate large volumes of chemical reactions to develop new materials for medicine and batteries.
The Palo Alto, California-based startup will help expand the capabilities of CUDA, Nvidia’s software platform for developing artificial intelligence applications, to better simulate the quantum mechanics behind chemical, biological and material science.